H.R.2416
Congress: 114th
Sponsor: Representative Burgess, Michael C. (05/19/2015)
Committees: House - Energy and Commerce
Description: To amend the Federal Food, Drug, and Cosmetic Act to evaluate the potential use of evidence from clinical experience to help support the approval of new indications for approved drugs, and for other purposes.
Vote Result:
Lastest Action: 05/22/2015 Referred to the Subcommittee on Health. (All Actions)
Official: H.R.2416 -- 114th Congress
- 0 Comments